Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
150 participants
OBSERVATIONAL
2023-10-01
2026-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions the study aims to answer are:
1. how does blood pressure measured using radar compare with blood pressure using a cuff in patients with known high blood pressure?
2. how does blood pressure measured using radar compare with invasive blood pressure during a coronary angiogram?
3. can the radar blood pressure machine be used to measure blood pressuring during an MRI scan of the heart?
4. can the radar blood pressure machine be used to measure blood pressure during exercise?
Participants in this study will have the following tests:
Group 1: blood pressure measured with the radar device and a cuff when resting Group 2: blood pressure measured with the radar device and by placing a small tube inside the arteries of the wrist (during a clinical procedure) Group 3: blood pressure measured with the radar device and a cuff during a cardiac MRI scan Group 4: blood pressure measured with the radar device and a cuff during exercise
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Accuracy Study of a Non-Invasive Blood Pressure Cuff in Comparison to an Invasive Radial Arterial Blood Pressure
NCT01485120
Wrist Worn Blood Pressure Measurement
NCT03919136
Validation of a Noninvasive Automated Blood Pressure Device
NCT03566888
Validation of the Blood Pressure Monitoring Function
NCT06104501
Non-invasive Validation of Non-invasive Central Blood Pressure Measurements Using Oscillometric Pulse Wave Analysis
NCT03049709
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators have used advanced but safe radar to create a small machine with a camera that can measure blood pressure from a distance without the need to contact the participant's skin anywhere. It works by detecting tiny movements and changes on the skin produced from the heartbeat and pulse that cannot be seen with the human eye. The investigators want to study how accurate our radar blood pressure machine is by comparing it to other traditional methods of measuring blood pressure.
Firstly, radar blood pressure will be compared to auscultatory blood pressure (a blood pressure system using a cuff) in a group of 25 participants at rest attending a specialist blood pressure clinic. This is currently the internationally recommended method for validating new blood pressure devices.
Then radar blood pressure will be compared with invasive blood pressure (measured inside the arteries by a small tube) in 50 participants undergoing clinically-indicated cardiac catheterisation at the Royal Free Hospital.
Next a radar device capable of measuring blood pressure in participants lying inside the cardiovascular magnetic resonance (CMR) scanner will be developed. The radar blood pressure derived in the CMR scanner will be compared to oscillometric blood pressure in 25 participants (a cuff-based BP system that is currently used in patients being scanned). Finally, radar-BP will be compared with oscillometric BP in 50 participants during exercise including sit-to-stand movements and using a bike ergometer.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Comparing radar and auscultatory blood pressure
25 participants will be recruited from a specialist hypertension clinic. These participants will undergo the following tests:
1. Questionnaire: The participant will be asked to complete a clinico-demographic questionnaire. This includes their demographic data and past medical history.
2. Measurement of height, weight and heart rate
3. Measurement of blood pressure using the radar device and using a cuff (called manual auscultation)
4. End of visit.
Radar blood pressure device
The radar blood pressure device will be compared with other traditional blood pressure measurement methods.
Comparing radar and invasive blood pressure
Participants will be recruited from a list of patients scheduled to attend the Royal Free Hospital catheterisation laboratory for a clinically-indicated invasive angiogram that was booked by their consultant. 50 participants aged 18 and over will be recruited.
The radar blood pressure measurements taken during the angiogram will not impact on the procedure or standard clinical care which the participant will receive. The duration of the visit is determined by the duration of the coronary angiogram and that is decided by the clinical care team. Participants will have the following tests:
1. Collection of baseline data including past medical history, current medication, height, weight and baseline ECG
2. Measurement of invasive blood pressure and radar blood pressure simultaneously before the rest of the procedure
3. End of visit.
Radar blood pressure device
The radar blood pressure device will be compared with other traditional blood pressure measurement methods.
Testing if the radar device can measure blood pressure in the MRI scanner
First we will develop a radar blood pressure device that can be used in the MRI scanner.
When this device has been proven to be safe, we will recruit 25 participants to have the following tests:
1. A questionnaire. The participant will be asked to complete a clinic-demographic questionnaire including their demographic data and past medical history.
2. Collection of blood test to assess kidney function. Additional blood tests will also be collected for storage and future analysis.
3. A cardiac MRI scan. Blood pressure will be measured at 5 minute intervals during the scan using an oscillometric cuff around the right upper arm. The radar device will measure blood pressure in a contactless way at the same time.
4. End of visit.
Radar blood pressure device
The radar blood pressure device will be compared with other traditional blood pressure measurement methods.
Testing if the radar device can measure blood pressure during exercise
We will recruit 50 participants the have the following tests:
1. Questionnaire: The participant will be asked to complete a clinico-demographic questionnaire. This includes their demographic data and past medical history.
2. Measurement of heart rate, breathing rate and oxygen saturations.
3. Recording a heart tracing called an ECG
4. Participants will then perform 5-10 minutes of exercise, either repeated sit-to-stand movements or using a bike ergometer. Blood pressure will be measured using a cuff and the radar device at regular intervals
5. Participants will then have a heart scan called an echocardiogram during which time the radar blood measurements will also be collected.
6. End of visit.
Radar blood pressure device
The radar blood pressure device will be compared with other traditional blood pressure measurement methods.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Radar blood pressure device
The radar blood pressure device will be compared with other traditional blood pressure measurement methods.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18 years old
* under the care of the complex hypertension clinic
* able to take auscultatory blood pressure from right arm
Group 2:
* Age \>18
* has been selected to undergo invasive coronary angiogram by a consultant cardiologist
Group 3:
* Age \>18
* willing to undergo a cardiac MRI scan
Group 4:
\- Age \> 18
Exclusion Criteria
* anyone unable to consent
* inaudible Korotkoff K1/K5 sounds
* systolic BP difference \>12 mmHg and/or diastolic \>8 mmHg in any of the auscultatory measurements during the validation study
* contraindication to cuff-based BP measurement e.g. lymph node clearance on right side
Group 2:
* anyone unable to consent
* anyone in whom right radial arterial access cannot be obtained (e.g. severe skin abnormality such as scleroderma)
* known arterio-venous malformation or fistulas in right arm
* any contraindication to an invasive angiogram such as severe frailty
Group 3:
* anyone unable to consent
* anyone with a classical contraindication to an MRI study such as known metal fragments allergy to used contrast
* high degree heart block
* asthma
Group 4:
* anyone unable to consent
* anyone with exertional chest pain or known uncontrolled angina
* anyone with a known positive cardiac stress test.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University College, London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gabriella Captur, PhD
Role: PRINCIPAL_INVESTIGATOR
University College, London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCL Bloomsbury Centre for Clinical Phenotyping
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRAS ID: 328944
Identifier Type: OTHER
Identifier Source: secondary_id
160695
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.